Close Menu

Eli Lilly

SeqWright will use the sequencing and sequence capture technologies to identify disease variants.

An Alexandria official would not discuss whether the deal would hasten a decision to begin the project's second phase, which has been delayed due to the ongoing economic upheaval.

Sirius will work with a system of 37 hospitals to test biomarkers for severe sepsis drug response.

The agreement is an extension of an existing deal between the two companies for access to Cerep's GPCR screening portfolio.

Findings from the initiative "could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions," the company said.

Linguamatics plans this year to continue building a customer base among large pharmaceutical firms, while Bioalma is eyeing the academic market to help drive growth in 2009.

News Scan

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

The agreement extends a screening collaboration between the firms into a fourth year.

Pages

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.